A Slimmed-Down Pfizer Sets A New R&D Goal: 25 Launches By 2025
The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.
The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.